- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4965 - Non-condensed pyrazines
Patent holdings for IPC class A61K 31/4965
Total number of patents in this class: 1804
10-year publication summary
|
89
|
91
|
103
|
108
|
106
|
137
|
125
|
117
|
83
|
84
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10656 |
49 |
| Nippon Shinyaku Co., Ltd. | 322 |
43 |
| Actelion Pharmaceuticals Ltd | 529 |
38 |
| Parion Sciences, Inc. | 58 |
33 |
| Vertex Pharmaceuticals Incorporated | 1623 |
28 |
| FUJIFILM Toyama Chemical Co., Ltd. | 112 |
23 |
| F. Hoffmann-La Roche AG | 7932 |
20 |
| Janssen Pharmaceutica N.V. | 3349 |
19 |
| Morehouse School of Medicine | 157 |
19 |
| Boehringer Ingelheim International GmbH | 4648 |
18 |
| Medibeacon, Inc. | 137 |
18 |
| Guangzhou Magpie Pharmaceuticals Co., Ltd. | 29 |
18 |
| Bristol-myers Squibb Company | 4848 |
17 |
| AstraZeneca AB | 2857 |
17 |
| Toyama Chemical Co., Ltd. | 99 |
17 |
| Abbvie Inc. | 1812 |
16 |
| Merck Sharp & Dohme LLC | 3734 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2615 |
14 |
| The Regents of the University of California | 20230 |
12 |
| Merck Sharp & Dohme Corp. | 2190 |
12 |
| Other owners | 1357 |